HUTCHMED (China) Ltd at Goldman Sachs Healthcare Conference Transcript
Good morning, everyone. I'm Paul Choi, and I cover the U.S. biotechnology sector here at Goldman Sachs, and it's our pleasure to welcome you those are here and online to our conference. Before we begin, we are required to make certain disclosures in public appearances about Goldman Sachs' relationship with the companies that we discuss.
Disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to U.S. clients on our firm's portal. In addition, updates to these disclosures are available by ticker on the firm's public website at https://www.gs.com/research/hedge.html.
Goldman Sachs agrees to host this conference on the basis that no third-party speaker will provide confidential or material nonpublic information. In addition
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |